MYR 0.61
(0.83%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 114.11 Million MYR | 5.51% |
2022 | 108 Million MYR | 21.49% |
2021 | 88.89 Million MYR | 53.22% |
2020 | 58.02 Million MYR | -7.47% |
2019 | 62.7 Million MYR | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 28.21 Million MYR | -10.19% |
2024 Q2 | 32.04 Million MYR | 13.63% |
2023 Q3 | 28.54 Million MYR | 2.33% |
2023 FY | 113.95 Million MYR | 5.51% |
2023 Q2 | 27.89 Million MYR | 6.93% |
2023 Q1 | 26.09 Million MYR | -8.34% |
2023 Q4 | 31.41 Million MYR | 10.05% |
2022 Q3 | 28.79 Million MYR | 0.0% |
2022 FY | 108 Million MYR | 21.49% |
2022 Q4 | 28.46 Million MYR | -1.13% |
2021 FY | 88.89 Million MYR | 53.22% |
2020 FY | 58.02 Million MYR | -7.47% |
2019 FY | 62.7 Million MYR | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Artroniq Berhad | 38.33 Million MYR | -197.712% |
QES Group Berhad | 240.66 Million MYR | 52.584% |
Pharmaniaga Berhad | 3.4 Billion MYR | 96.648% |
Apex Healthcare Berhad | 936.16 Million MYR | 87.81% |